These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 21480003)
1. PTMs in conversation: activity and function of deubiquitinating enzymes regulated via post-translational modifications. Kessler BM; Edelmann MJ Cell Biochem Biophys; 2011 Jun; 60(1-2):21-38. PubMed ID: 21480003 [TBL] [Abstract][Full Text] [Related]
2. Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code. Wang Y; Wang F Front Pharmacol; 2021; 12():685011. PubMed ID: 34177595 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Deubiquitinase Specificity and Regulation. Mevissen TET; Komander D Annu Rev Biochem; 2017 Jun; 86():159-192. PubMed ID: 28498721 [TBL] [Abstract][Full Text] [Related]
4. Dissenting degradation: Deubiquitinases in cell cycle and cancer. Bonacci T; Emanuele MJ Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366 [TBL] [Abstract][Full Text] [Related]
6. Emerging Roles of USP18: From Biology to Pathophysiology. Kang JA; Jeon YJ Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957626 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098 [TBL] [Abstract][Full Text] [Related]
8. Putative role of SUMOylation in controlling the activity of deubiquitinating enzymes in cancer. Masoumi KC; Marfany G; Wu Y; Massoumi R Future Oncol; 2016 Feb; 12(4):565-74. PubMed ID: 26777062 [TBL] [Abstract][Full Text] [Related]
10. Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint. Lim KH; Song MH; Baek KH Cell Mol Life Sci; 2016 Apr; 73(7):1439-55. PubMed ID: 26762302 [TBL] [Abstract][Full Text] [Related]
11. Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases. Hewitt CS; Krabill AD; Das C; Flaherty DP Biochemistry; 2020 Sep; 59(37):3447-3462. PubMed ID: 32865982 [TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications: Regulators of neurodegenerative proteinopathies. Gupta R; Sahu M; Srivastava D; Tiwari S; Ambasta RK; Kumar P Ageing Res Rev; 2021 Jul; 68():101336. PubMed ID: 33775891 [TBL] [Abstract][Full Text] [Related]
13. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases. Seiberlich V; Goldbaum O; Zhukareva V; Richter-Landsberg C Biochim Biophys Acta; 2012 Nov; 1823(11):2057-68. PubMed ID: 22565157 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk between SUMOylation and other post-translational modifications in breast cancer. Wei B; Yang F; Yu L; Qiu C Cell Mol Biol Lett; 2024 Aug; 29(1):107. PubMed ID: 39127633 [TBL] [Abstract][Full Text] [Related]
15. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes. Doherty LM; Mills CE; Boswell SA; Liu X; Hoyt CT; Gyori B; Buhrlage SJ; Sorger PK Elife; 2022 Jun; 11():. PubMed ID: 35737447 [TBL] [Abstract][Full Text] [Related]